Are you developing a digital health solution with cross-border reach? Whether your company is new to the digital health space, or enhancing its existing digital health offering in response to COVID‑19, we’ve got you covered on the top legal issues. Take a look at our survey covering key markets like the UK, France, Germany, Italy, Russia and Spain.

COVID‑19 is accelerating the adoption of digital health solutions by hospitals and medical institutions around the world. Companies are innovating at lightning speed to adapt to new needs: patients are being treated remotely through mobile doctor apps, symptom-checking bots are triaging patients and providing tailored advice, and new remote consultation and tracking solutions are hitting the market fast.

There has never been a more urgent need to help strained healthcare systems and patients. But even in the current climate, regulators are emphasizing the need to balance innovation and safety.

This feature was first posted on Baker McKenzie InsightPlus. Click here for the original publication.

Author

Jaspreet is a Senior Associate, and advises clients on complex issues at the intersection of healthcare, data and technology. Her practice has a particular focus on accessing and using patient data, innovative collaborations with hospitals, and the use and regulation of AI in the healthcare space.

Author

Write A Comment